Meredith Elise Osborne, | |
Joint Relief Institute, 600 22nd Street, Oak Brook, IL 60523 | |
(708) 914-5145 | |
Not Available |
Full Name | Meredith Elise Osborne |
---|---|
Gender | Female |
Speciality | Pain Medicine - Pain Medicine |
Location | Joint Relief Institute, Oak Brook, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881244614 | NPI | - | NPPES |
085.007237 | Other | IL | ILLINOIS STATE PHYSICIAN ASSISTANT LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0000X | Pain Medicine - Pain Medicine | 085.007237 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Meredith Elise Osborne, 3631 N Magnolia Ave Apt 3, Chicago, IL 60613-0256 Ph: (678) 602-8195 | Meredith Elise Osborne, Joint Relief Institute, 600 22nd Street, Oak Brook, IL 60523 Ph: (708) 914-5145 |
News Archive
The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - today said physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.
Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection.
Hops, those little cone-shaped buds that give beer its bitter flavor, pack a surprisingly healthful punch. They are widely studied for their ability to halt bacterial growth and disease. Now, researchers report that they are close to synthesizing the healthful hops compounds in the lab. This advance could one day help scientists create medicines from these compounds without having to extract them from plants.
Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine vaccines, will present data at this week's DNA Vaccines 2010 in New Orleans, LA concerning the formulation and topical administration of the DermaVir therapeutic vaccine for HIV/AIDS. DNA Vaccine 2010 invites leading scientists to report on the latest research in the progressive field of DNA or Genetic Vaccines.
In continuation of Radiometer's commitment to the fight against sepsis – one of the world's deadliest diseases - Radiometer is proud to sponsor World Sepsis Day for the second consecutive year.
› Verified 4 days ago